Cipta Sarana Medika Tbk. vs Magna Investama Mandiri Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 20.3M 24h volume), while Magna Investama Mandiri Tbk. trades at Rp92 (market cap 310.41B, 266.5K 24h volume). The key difference: Magna Investama Mandiri Tbk. is the larger of the two by market cap, and Cipta Sarana Medika Tbk. is more actively traded (20.3M versus 266.5K). Which is the better fit depends on your goals.
| DKHH | MGNA | |
|---|---|---|
Market Cap | 160.67B | 310.41B |
Volume | 20.3M | 266.5K |
Lot | 203.05K | 2.67K |
Turnover | 1.33B | 24.39M |
Average Price | 65.3 | 91.53 |
Value | 1.33B | 24.39M |
Indicative Equilibrium Price | 64 | 92 |
Indicative Equilibrium Volume | 1.35K | 38 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Magna Finance Tbk (the Company) formerly PT Arkasa Utama Leasing was established based on Notarial Deed No. 10 dated March 09, 1984 of James Jacinta Susanti, S.H.
Read more on MGNA →